National Bank of Canada’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.89K | Buy |
134
+117
| +688% | +$2.52K | ﹤0.01% | 2215 |
|
|
2025
Q1 | $276 | Sell |
17
-867
| -98% | -$14.1K | ﹤0.01% | 2350 |
|
|
2024
Q4 | $16.2K | Sell |
884
-100
| -10% | -$1.84K | ﹤0.01% | 1858 |
|
|
2024
Q3 | $15.1K | Sell |
984
-1
| -0.1% | -$15 | ﹤0.01% | 1811 |
|
|
2024
Q2 | $15.8K | Hold |
985
| – | – | ﹤0.01% | 1872 |
|
|
2024
Q1 | $15K | Buy |
985
+550
| +126% | +$8.38K | ﹤0.01% | 1898 |
|
|
2023
Q4 | $13.4K | Buy |
435
+105
| +32% | +$3.24K | ﹤0.01% | 1929 |
|
|
2023
Q3 | $7.08K | Hold |
330
| – | – | ﹤0.01% | 2056 |
|
|
2023
Q2 | $7.9K | Hold |
330
| – | – | ﹤0.01% | 2070 |
|
|
2023
Q1 | $6.21K | Hold |
330
| – | – | ﹤0.01% | 2108 |
|
|
2022
Q4 | $5.25K | Hold |
330
| – | – | ﹤0.01% | 2150 |
|
|
2022
Q3 | $5K | Buy |
330
+35
| +12% | +$530 | ﹤0.01% | 2144 |
|
|
2022
Q2 | $4K | Hold |
295
| – | – | ﹤0.01% | 2238 |
|
|
2022
Q1 | $7K | Buy |
+295
| New | +$7K | ﹤0.01% | 2217 |
|